In fact, the Hansford et al. study found that only 34 out of 183, or not even 20% of patients with clinical diagnosis of HDGC, harbored CDH1 mutations [4]. This evidence concerns the gene CDH1 and CDH1-related diffuse gastric and lobular breast cancer syndrome.